{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:33Z","timestamp":1790266893583,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20230371"],"award-info":[{"award-number":["20230371"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["FoUI-986028"],"award-info":[{"award-number":["FoUI-986028"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-01807"],"award-info":[{"award-number":["2023-01807"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304245"],"award-info":[{"award-number":["82304245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.ajkd.2026.02.642","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:51:06Z","timestamp":1776523866000},"page":"88-98.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks of Hypocalcemia and Other Bone Mineral Disorders for Denosumab Versus Zoledronate Across the Spectrum of Kidney Function: A Target Trial Emulation"],"prefix":"10.1053","volume":"88","author":[{"given":"Ruowei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Faucon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad K.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongze","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-608X","authenticated-orcid":false,"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jesus","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.ajkd.2026.02.642_bib1","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/gfz142","article-title":"Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project","volume":"35","author":"Runesson","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2026.02.642_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18433\/J3RK5J","article-title":"Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back","volume":"15","author":"Salari","year":"2012","journal-title":"J Pharm Pharm Sci"},{"issue":"8","key":"10.1053\/j.ajkd.2026.02.642_bib3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1053\/j.ajkd.2026.02.642_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"10329","key":"10.1053\/j.ajkd.2026.02.642_bib5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.ajkd.2026.02.642_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2026.02.642_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","volume":"331","author":"Bird","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2026.02.642_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/hdi.13098","article-title":"Effects of denosumab on bone mineral density and bone metabolism in patients with end-stage renal disease: a systematic review and meta-analysis","volume":"27","author":"Gu","year":"2023","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib9","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/M24-0013","article-title":"The effect of denosumab on risk for emergently treated hypocalcemia by stage of chronic kidney disease: a target trial emulation","volume":"178","author":"Bird","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2026.02.642_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117045","article-title":"Sustained hypophosphatemia after denosumab in a patient on hemodialysis","volume":"181","author":"Almodares","year":"2024","journal-title":"Bone"},{"issue":"8","key":"10.1053\/j.ajkd.2026.02.642_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000518363","article-title":"Denosumab-induced hypocalcemia and hyperparathyroidism in de novo kidney transplant recipients","volume":"52","author":"Cianciolo","year":"2021","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.02.642_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/joim.13418","article-title":"The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care","volume":"291","author":"Carrero","year":"2022","journal-title":"J Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2026.02.642_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7326\/ANNALS-24-01871","article-title":"The target trial framework for causal inference from observational data: why and when is it helpful?","volume":"178","author":"Hern\u00e1n","year":"2025","journal-title":"Ann Intern Med"},{"issue":"5893","key":"10.1053\/j.ajkd.2026.02.642_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"BMJ"},{"issue":"10","key":"10.1053\/j.ajkd.2026.02.642_bib17","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/ckj\/sfab006","article-title":"Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease","volume":"14","author":"Xu","year":"2021","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1053\/j.ajkd.2026.02.642_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40620-023-01860-0","article-title":"Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project","volume":"37","author":"Gonzalez-Ortiz","year":"2024","journal-title":"J Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2026.02.642_bib19","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/ndt\/gfy283","article-title":"Merits and caveats of propensity scores to adjust for confounding","volume":"34","author":"Fu","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2021","journal-title":"Clin Kidney J"},{"issue":"19","key":"10.1053\/j.ajkd.2026.02.642_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2026.02.642_bib22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ndt\/gfad219","article-title":"Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care","volume":"39","author":"Fu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2026.02.642_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/sim.5922","article-title":"Number needed to treat for time-to-event data with competing risks","volume":"33","author":"Gouskova","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12963-025-00364-2","article-title":"How much missing data is too much to impute for longitudinal health indicators? A preliminary guideline for the choice of the extent of missing proportion to impute with multiple imputation by chained equations","volume":"23","author":"Junaid","year":"2025","journal-title":"Popul Health Metr"},{"issue":"15","key":"10.1053\/j.ajkd.2026.02.642_bib25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2026.02.642_bib26","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"2004"},{"issue":"14","key":"10.1053\/j.ajkd.2026.02.642_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/sim.7654","article-title":"Bootstrap inference when using multiple imputation","volume":"37","author":"Schomaker","year":"2018","journal-title":"Stat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"key":"10.1053\/j.ajkd.2026.02.642_bib29","series-title":"The Bootstrap and Edgeworth Expansion","author":"Hall","year":"2013"},{"issue":"24","key":"10.1053\/j.ajkd.2026.02.642_bib30","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/sim.7822","article-title":"High-dimensional variable selection and prediction under competing risks with application to SEER-Medicare linked data","volume":"37","author":"Hou","year":"2018","journal-title":"Stat Med"},{"issue":"7","key":"10.1053\/j.ajkd.2026.02.642_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jbmr\/zjae059","article-title":"Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases","volume":"39","author":"Tan","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.ajkd.2026.02.642_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jbi.2016.12.005","article-title":"Accuracy of an automated knowledge base for identifying drug adverse reactions","volume":"66","author":"Voss","year":"2017","journal-title":"J Biomed Inform"},{"issue":"22","key":"10.1053\/j.ajkd.2026.02.642_bib33","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/sim.3971","article-title":"Sensitivity analysis for misclassification in logistic regression via likelihood methods and predictive value weighting","volume":"29","author":"Lyles","year":"2010","journal-title":"Stat Med"},{"issue":"3","key":"10.1053\/j.ajkd.2026.02.642_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/EDE.0000000000001714","article-title":"A quantitative bias analysis approach to informative presence bias in electronic health records","volume":"35","author":"Zhang","year":"2024","journal-title":"Epidemiology"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-263129","article-title":"Severe hypophosphataemia following denosumab administration successfully managed using a calcimimetic agent","volume":"18","author":"Omori","year":"2025","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.ajkd.2026.02.642_bib36","article-title":"Severe hypocalcemia and dramatic increase in parathyroid hormone after denosumab in a dialysis patient: a case report and review of the literature","volume":"2019","author":"Bhanot","year":"2019","journal-title":"Case Rep Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ckj\/sfs158","article-title":"Dramatic increase in parathyroid hormone and hypocalcaemia after denosumab in a kidney transplanted patient","volume":"6","author":"Torregrosa","year":"2013","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.ajkd.2026.02.642_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000380960","article-title":"Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5","volume":"41","author":"Dave","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2026.02.642_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117407","article-title":"Parathyroid hormone levels following denosumab vs zoledronic acid therapy for osteoporosis","volume":"193","author":"Rotman-Pikielny","year":"2025","journal-title":"Bone"},{"issue":"8","key":"10.1053\/j.ajkd.2026.02.642_bib40","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib41","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1053\/j.ajkd.2026.02.642_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40264-019-00888-1","article-title":"Drug-induced hypophosphatemia: current insights","volume":"43","author":"Megapanou","year":"2020","journal-title":"Drug Saf"},{"issue":"20","key":"10.1053\/j.ajkd.2026.02.642_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012223","article-title":"Mineral bone disorders in kidney disease patients: the ever-current topic","volume":"23","author":"Hu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1053\/j.ajkd.2026.02.642_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.ajkd.2023.04.017","article-title":"Calcium and phosphate disorders: core curriculum 2024","volume":"83","author":"Murray","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2026.02.642_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","article-title":"Vitamin D therapy in chronic kidney disease and end stage renal disease","volume":"7","author":"Melamed","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.02.642_bib46","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00198-024-07118-0","article-title":"Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials","volume":"35","author":"Kobayashi","year":"2024","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.02.642_bib47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbmr.4157","article-title":"Cardiovascular safety of denosumab across multiple indications: a systematic review and meta-analysis of randomized trials","volume":"36","author":"Seeto","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1053\/j.ajkd.2026.02.642_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease\u2013mineral and bone disorder: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:15:23Z","timestamp":1785874523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626008498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0272638626008498"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.02.642","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks of Hypocalcemia and Other Bone Mineral Disorders for Denosumab Versus Zoledronate Across the Spectrum of Kidney Function: A Target Trial Emulation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.02.642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}